Press release
Theranostics Market in 2025 Detailed Study Analysis
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued at USD 2.48 Bn in 2024 and is predicted to reach USD 9.33 Bn by the year 2034 at a 14.4% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2344
Theranostics represents an emerging field that bridges the gap between conventional medicine and modern personalized and precision medicine by integrating therapeutics, nanotechnology, and diagnostics. The application of theranostics in precision medicine has significantly enhanced cancer patient care. Physicians utilize specific biomarkers to assess treatment efficacy, which supports informed decision-making in medication selection and improves treatment success rates.
By aligning with precision medicine's goal of understanding the biological basis of diseases, theranostics offers advanced diagnostic tools to identify patients who would derive the greatest benefit from targeted therapies.
The market is expected to grow due to the rising incidence of cancer and the increasing focus on personalized treatment approaches. However, the expansion of the global theranostics industry may be hindered by challenges such as insufficient reimbursement policies and the lack of clearly defined regulations governing theranostics testing in several countries.
List of Prominent Players in the Theranostics Market:
• Advanced Accelerator Applications
• Bayer AG
• GE Healthcare
• Siemens healthiness Ag
• Cardinal Health
• Philips Healthcare
• Canon Inc
• Curium
• Lantheus
• Northstar Medical Radioisotopes
• Eckert & Ziegler
• Pharmacologic
• Eczacibasi -Monroe
• Acrotech Biopharma Inc.
• Others
Market Dynamics:
Drivers-
The increasing prevalence of cancer and chronic diseases, along with rising investments in biological research, is driving the demand for theranostics. The global theranostics market is poised for significant growth as the need for efficient and targeted treatment solutions continues to rise, regardless of cost considerations. Theranostics play a critical role in precision medicine by providing diagnostic tools that identify patients who would derive the greatest benefit from specific treatments. Consequently, the growing incidence of cancer and the demand for personalized therapies are expected to propel market expansion.
Curious about this latest version of the report? @https://www.insightaceanalytic.com/enquiry-before-buying/2344
Challenges:
Despite its growth potential, the theranostics market faces several challenges, including high costs, a shortage of skilled professionals, and a lack of standardized protocols, particularly in emerging markets affected by lockdowns and isolation measures. The substantial expenses associated with installing and maintaining advanced laboratory equipment, coupled with stringent government regulations for certifying new products, present significant barriers to market expansion.
Regional Trends:
North America is expected to dominate the theranostics market in terms of revenue and is projected to experience a high compound annual growth rate (CAGR) in the coming years. This growth is attributed to the rising incidence of cancer, increasing investments in theranostics, and the presence of specialized theranostics centers. Additionally, the rapidly growing elderly population in the region is further driving market expansion. Meanwhile, Europe holds a substantial market share, supported by the presence of major industry players and a well-established pharmaceutical and healthcare infrastructure.
Recent Developments:
• In January 2024, Cardinal Health updated its non-GAAP diluted EPS projection and announced new enterprise operating and segment reporting structures as part of its continuing business and portfolio assessment. These updates strengthen the company's momentum, commitment to creating wealth over the long term, and ongoing efforts to become more focused and efficient.
• In January 2024, Bayer is revamping the Executive Leadership Team of the Crop Science Division. With the new setup, the company can strive to be the leading voice in regenerative agriculture, which will profoundly impact farmers, customers, and the globe at large.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2344
Segmentation of Theranostics Market-
By Product
• Diagnostic Imaging
• Radiopharmaceuticals
• IVD/Biomarker Screening
• Software and Services
By Application
• Prostate Cancer
• Bone Metastasis
• Other Cancers
• Other Applications
By End User
• Hospitals and Cancer Care Centers
• Theranostics Centers
• Research and Academic Centers
By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information: @
https://www.insightaceanalytic.com/report/theranostics-market/2344
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market in 2025 Detailed Study Analysis here
News-ID: 4137029 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Animal Drug Compounding Market Deep Research Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Animal Drug Compounding Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Livestock Animals), By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones & Substitutes, CNS Agents, GI Drugs), By Route of Administration (Oral, Injectable, Topical), By Dosage Form (Suspensions, Solutions, and Capsules)- Market Outlook And Industry Analysis 2034"
The global Animal Drug Compounding market…
Artificial Intelligence (AI) In Dental Imaging Market for Personalized Treatment …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence (AI) In Dental Imaging Market Size, Share & Trends Analysis Report By Vehicle (Light commercial vehicles, Medium commercial vehicles, Heavy commercial vehicles), Fuel Cell Technology (Proton exchange membrane, Alkaline fuel cells, Solid oxide fuel cells), Range (Short-range, Medium-range, Long-range), End User (Public transit, Construction and mining, Logistics & transportation, Others)- Market Outlook And…
AI-Enhanced Minimally Invasive Devices Market Market Drivers, Challenges, and Op …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI-Enhanced Minimally Invasive Devices Market Size, Share & Trends Analysis Report By Product Type (AI-Enhanced Catheters, AI-Powered Endoscopy Systems, Robotic-Assisted Surgical Systems, Imaging and Visualization Devices, Other Devices), Application (Cardiology, Gastroenterology, Interventional Radiology, Orthopedics, Urology and Gynecology, Others), End User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics), Technology (Machine Learning, Computer Vision, Natural Language Processing…
AI in Pharmacovigilance Market Reducing Operational Costs and Enhancing Accuracy
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Pharmacovigilance Market Size, Share & Trends Analysis Report By Component (Software, Services), Deployment (On-premises, Cloud-based), End User (Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Others) -Market Outlook And Industry Analysis 2034"
Global AI in Pharmacovigilance Market Size is predicted to grow at an 14.6% CAGR during the forecast period for 2025-2034.
Get Free Access…
More Releases for Theranostics
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
Theranostics Market: Opportunities and Forecasts, 2016 - 2024
Global Theranostics Market: Overview
Theranostics is considered as a fusion of diagnostics and drug therapy. It helps in optimizing safety, effective results, and streamlining of overall drug development. The combination of advanced diagnostic tests and effective medical drugs has been given several names, such as pharmacodiagnostics, integrated medicine, Dx/Rx partnering, and companion diagnostics. Research activities in this field are contributing extensively towards the growth of the market, as this is considered…
